Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
West Pharmaceutical Services ( (WST) ) just unveiled an update.
West Pharmaceutical Services announced its financial results for the fourth quarter and full year 2024, revealing a 2.3% increase in net sales in the fourth quarter, driven by a strong demand in their Proprietary Products segment, particularly self-injection devices. Despite a decline in full-year 2024 net sales by 1.9%, the company remains optimistic for 2025 with projected net sales growth and continued momentum in key areas, although it faces potential headwinds due to foreign currency exchange rates.
More about West Pharmaceutical Services
West Pharmaceutical Services operates in the healthcare industry, specializing in the production of innovative solutions for injectable drug administration, including self-injection device platforms and high-value products for biologics and generics markets.
YTD Price Performance: -1.55%
Average Trading Volume: 487,790
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $23.34B
Find detailed analytics on WST stock on TipRanks’ Stock Analysis page.
